Sandra Shpilberg is the Co-Founder and COO at Adnexi, an AI-powered platform that profiles and evaluates Patient Advocacy Groups by therapeutic area to enable biopharma patient-centric strategies—from clinical trials to treatment launch.
Sandra is an accomplished life science executive and serial entrepreneur. Prior to Adnexi, she founded and led multiple ventures, including Sanaby Health—a special purpose acquisition company focused on accelerating healthcare innovation—and Seeker Health, a digital patient-finding platform that improved clinical trial recruitment.
She has held executive roles at leading biopharmaceutical companies, including Nora Therapeutics and BioMarin Pharmaceutical, where she led the commercial launches of multiple drug therapies.
